Innovative gene therapy marks a turning point for a young patient with sickle cell disease
Last week at Children's National Hospital in Washington, D.C., a significant medical event occurred for 12-year-old Kendric Cromer, marking the beginning of what his doctors are calling a new chapter in his life. Kendric, who has battled sickle cell disease since birth, received a groundbreaking gene therapy treatment recently approved by the FDA. The innovative therapy, which aims to alleviate the symptoms of sickle cell disease, was administered in the hopes of giving Kendric a more normal childhood, free from the frequent and painful episodes that are characteristic of the disease. The day of treatment was supposed to be a…
